NASDAQ:LIFE
aTyr Pharma, Inc.
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
www.atyrpharma.comipo date
May 07, 2015
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for treatment of other interstitial l...Show More
Earnings
Earnings Release in 18 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus